Huiting Wei
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
-
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- interferon and immune responses
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Cell death mechanisms and regulation 2
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Oncology 4
- Co-authors
- Junying Yuan (2 shared papers)Zhi Yao (4 shared papers)Kezhou Zhu (1 shared paper)Ying Li (1 shared paper)Shao‐Cong Sun (1 shared paper)Huibing Wang (1 shared paper)Huyan Meng (1 shared paper)Xingyan Li (1 shared paper)
- Journals
- Genomics Proteomics & Bioinformatics (1 paper)Evidence-based Complementary and Alternative Medicine (1 paper)Oncotarget (1 paper)Experimental and Clinical Endocrinology & Diabetes (1 paper)Frontiers in Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Huiting Wei
12 papers receiving 538 citations
Peers
Comparison fields: 5 of 72
- Oncology 205
- Immunology 142
- Molecular Biology 328
- Cancer Research 57
- Geriatrics and Gerontology 9
Countries citing papers authored by Huiting Wei
This map shows the geographic impact of Huiting Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiting Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiting Wei more than expected).
Fields of papers citing papers by Huiting Wei
This network shows the impact of papers produced by Huiting Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiting Wei. The network helps show where Huiting Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiting Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 236 | |
| 2 | 2017 | 96 | |
| 3 | 2017 | 76 | |
| 4 | 2018 | 42 | |
| 5 | 2017 | 41 | |
| 6 | 2022 | 15 | |
| 7 | 2013 | 13 | |
| 8 | 2016 | 13 | |
| 9 | 2020 | 4 | |
| 10 | 2025 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2024 | 3 |
About Huiting Wei
Huiting Wei is a scholar working on Molecular Biology, Oncology, Surgery, Endocrinology and Immunology, having authored 12 papers that have together received 546 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Escherichia coli research studies (2 papers), Bladder and Urothelial Cancer Treatments (1 paper), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper), NF-κB Signaling Pathways (1 paper), Cancer Mechanisms and Therapy (1 paper) and Ureteral procedures and complications (1 paper). The work is most often cited by research in Oncology (205 citations), Immunology (142 citations), Molecular Biology (328 citations), Cancer Research (57 citations) and Geriatrics and Gerontology (9 citations). Huiting Wei has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Junying Yuan, Zhi Yao, Kezhou Zhu, Ying Li, Shao‐Cong Sun, Huibing Wang, Huyan Meng, Xingyan Li, Adnan K. Mookhtiar and Kangyun Dong. Their work appears in journals such as Genomics Proteomics & Bioinformatics, Evidence-based Complementary and Alternative Medicine, Oncotarget, Experimental and Clinical Endocrinology & Diabetes and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.